Access 2.8M+ Filings Sign Up Free
Isofol Medical Logo

Isofol Medical | ISOFOL - Profile, Filings, Stock Info & Investor Relations Data

Isofol Medical | ISOFOL
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
2008
Isofol Medical (ISOFOL)

Company Profile

Website
Investor Relations

About Isofol Medical

Isofol Medical AB (publ), founded in 2008, is a biotech company that is developing a new drug candidate for the treatment of advanced colorectal cancer.

Colorectal cancer (CRC) is the third most common form of cancer worldwide and there is a very high need for more effective drugs to treat this disease.

Vision:
“Isofol will help extend life and improve the quality of life for cancer patients”

Arfolitixorin is being developed and commercialized through a global licensing agreement with Merck & Cie in Germany. The licensing agreement also grants Isofol access to the unique patented manufacturing process for arfolitixorin.

Headquarters

C/O Biotech Center, Arvid Wallgrens
413 46, Göteborg
Sweden

Isofol Medical (ISOFOL)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Isofol Medical (ISOFOL)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Magnus Hurst (Other)
Buy SEK 24,150.00 SEK 0.69 11.01.24
↑
AB Windar (Other)
Buy SEK 305,000.00 SEK 0.61 12.09.22
↓
Tony Gustavsson (Other)
Sell SEK 858.00 SEK 0.01 09.12.21
↓
Tony Gustavsson (Other)
Sell SEK 152.79 SEK 0.00 09.12.21
↑
HealthCom GmbH (Other)
Buy SEK 1,493,350.40 SEK 6.40 14.06.21
◆
Gustaf Albèrt (Other)
Other SEK 96,979.20 SEK 6.40 10.06.21
↑
Tony Gustavsson (Other)
Buy SEK 43,487.58 SEK 0.74 23.11.20
↑
Tony Gustavsson (Other)
Buy SEK 29,971.17 SEK 0.51 23.11.20
↓
Sven Eriksson (Other)
Sell SEK 43,487.58 SEK 0.74 16.11.20
↓
Sven Eriksson (Other)
Sell SEK 29,971.17 SEK 0.51 16.11.20

Isofol Medical (ISOFOL)
Stock & Investor Information

ISINs

SE0009581051

LEI

549300MCXYAHG7VBHX75

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Biotechnology